Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Zhang

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|July 31, 2007
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trialSuzanne Oparil, Steven A Yarows, Samir Patel, et al.
Blood Pressure. Supplement|February 11, 2009
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-respondersGeorg Nickenig, Vladimir Simanenkov, Giuseppe Lembo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 17, 2018
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week studyDeanna G Cheung, Diego Aizenberg, Vladimir Gorbunov, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 5, 2012
Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label studyAlexander V Murray, Wolfgang Koenig, Juan Garcia-Puig, et al.
Journal of Experimental Psychology. Human Perception and Performance|April 29, 2016
The impact of configural superiority on the processing of spatial informationAlexander Bratch, Shawn Barr, W Drew Bromfield, et al.
Current Vascular Pharmacology|February 7, 2012
Antihypertensive efficacy and tolerability of aliskiren/amlodipine single- pill combinations in patients with an inadequate response to aliskiren monotherapyNicola Glorioso, Mathew Thomas, Chiara Troffa, et al.
Current Medical Research and Opinion|February 28, 2009
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg aloneMatthias Blumenstein, Jerzy Romaszko, Alberto Calderón, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 17, 2009
Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide aloneHelmut Geiger, Elizabeth Barranco, Manuel Gorostidi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 28, 2012
Histone deacetylase 6 associates with ribosomes and regulates de novo protein translation during arsenite stressKyle V Kappeler, Jack Zhang, Thai Nho Dinh, et al.
Lancet (London, England)|January 18, 2011
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trialMorris J Brown, Gordon T McInnes, Cheraz Cherif Papst, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|July 31, 2007
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trialSuzanne Oparil, Steven A Yarows, Samir Patel, et al.
Blood Pressure. Supplement|February 11, 2009
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-respondersGeorg Nickenig, Vladimir Simanenkov, Giuseppe Lembo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 17, 2018
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week studyDeanna G Cheung, Diego Aizenberg, Vladimir Gorbunov, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 5, 2012
Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label studyAlexander V Murray, Wolfgang Koenig, Juan Garcia-Puig, et al.
Journal of Experimental Psychology. Human Perception and Performance|April 29, 2016
The impact of configural superiority on the processing of spatial informationAlexander Bratch, Shawn Barr, W Drew Bromfield, et al.
Current Vascular Pharmacology|February 7, 2012
Antihypertensive efficacy and tolerability of aliskiren/amlodipine single- pill combinations in patients with an inadequate response to aliskiren monotherapyNicola Glorioso, Mathew Thomas, Chiara Troffa, et al.
Current Medical Research and Opinion|February 28, 2009
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg aloneMatthias Blumenstein, Jerzy Romaszko, Alberto Calderón, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 17, 2009
Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide aloneHelmut Geiger, Elizabeth Barranco, Manuel Gorostidi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 28, 2012
Histone deacetylase 6 associates with ribosomes and regulates de novo protein translation during arsenite stressKyle V Kappeler, Jack Zhang, Thai Nho Dinh, et al.
Lancet (London, England)|January 18, 2011
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trialMorris J Brown, Gordon T McInnes, Cheraz Cherif Papst, et al.
Pageof 8